Danaher Corporation
Danaher Corporation (DHR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · DHR · as of Jun 8, 2026
Key Statistics
Explore Danaher Corporation Data
dhr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 42 · Buy rate: 71.4%
The DHR analyst consensus is Buy, based on ratings from 42 Wall Street analysts over the past 3 months. The average 12-month price target is $238.30, representing +29.30% upside from the current price of $184.30.
Competitors & Peers
dhr competitorsDHR
AMGN
BSX
GILD
ISRG
MCKStock Performance
Full HistoryAbout Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Di…
what is danaher corporation · dhr stock overview · danaher corporation company profile · who is danaher corporation ceo · dhr NYSE · danaher corporation headquarters · danaher corporation business segments
About Stock Overview & Key Data
Danaher Corporation (DHR) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NYSE since Dec 29, 1978. As of the latest trading session, DHR stock price is $184.30, with a market capitalization of $130.4B. The stock has returned -7.48% over the past 12 months and -19.49% year-to-date.
According to 42 Wall Street analysts, the consensus rating for Danaher Corporation stock is Buy, with an average 12-month price target of $238.30. In fiscal year 2025, Danaher Corporation reported revenue of $24.6B and net income of $3.6B. For detailed data — including Danaher Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Danaher Corporation (DHR) stock price is $184.30. The stock is traded on NYSE under the ticker symbol DHR. The 52-week range is $160.93 – $242.80.